|
|
|
|
|
|
|
|
|
| Wednesday, March 7, 2012 |
|
6:00PM – 8:00PM |
Business Development Reception Hosted by BayBio & BIOCOM Chairs & Boards of Directors
Invitation Only Event |
|
| Thursday, March 8, 2012 |
|
7:00AM – 8:30AM |
Registration and Networking Breakfast |
|
8:30AM – 9:45AM |
|
|
|
|
|
Track 1
Capital Access |
Track 2
Clinical Development |
Track 3
Markets |
Track 4
Foundations |
|
|
10:00AM – 11:15AM |
Session 1 |
New Developments in VC Financings – Selling Your Soul? |
Patient Advocacy: The Key to the Next Evolution of Clinical Development |
Reimbursement: Will They Pay? The Changing Role of Payers in a Product’s Success |
10:00AM – 10:20AM
The Myelin Repair Foundation
10:25AM – 10:45AM
The Michael J. Fox Foundation
10:50AM – 11:10AM
Fast Forward |
Partnering |
Exhibits |
|
11:15AM – 11:45AM |
Coffee Break |
|
11:45AM – 1:00PM |
Session 2 |
Successful Collaborations with Passion Investors |
Ten Tips to Accelerate Clinical Trials and Do Them Well |
The Biotech Product Launch: Not Necessarily Destined for Failure |
11:45AM – 12:05PM
EveryLife Foundation
12:15PM – 12:25PM
Melanoma Research Alliance
12:30PM – 12:50PM
CIRM |
|
1:00PM – 1:30PM |
Lunch |
|
|
1:30PM – 2:45PM |
|
|
2:45PM – 4:00PM |
Session 3 |
Before You Look for Loose Change: Alternative Funding Sources for Biotech and How to Secure Them |
Emerging Issues in the Conduct of Global Clinical Trials |
Flexing Commercial Muscle Beyond the US |
2:45PM – 3:05PM
FasterCures
3:10PM – 3:30PM
The Leukemia & Lymphoma Society
3:35PM – 3:55PM
Critical Path Institute |
Partnering |
|
4:00PM – 4:15PM |
Coffee Break |
|
4:15PM – 5:30PM |
Session 4 |
Preparing for M&A: Engineering a Happy Marriage |
Modernizing our Industry: Developing the Clinical Trials of the Future |
Orphan and Ultra Orphan Drugs: Market Experiences & Opportunities |
4:15PM – 4:35PM
Partnership for Compassionate Use Therapies (PCUT) |
|
5:30PM – 7:00PM |
Opening Night Reception |
|
| Friday, March 9, 2012 |
|
7:30AM – 8:15AM |
Registration and Networking Breakfast |
Partnering |
Exhibits |
|
8:15AM – 9:30AM |
|
|
|
|
Track 1
Drug Discovery |
Track 2
Regulatory |
Track 3
Patients |
Track 4
Business Models |
|
9:45AM – 11:00AM |
Session 1 |
The Nine Components of Success in the New World of Life Sciences R&D |
Regulatory Risk: How Do We Manage? |
Taking Matters into Their Own Hands: The Role of Patients in Drug Development |
Life Sciences Innovation: A Fundable Future or Financial Flop? |
|
11:00AM – 11:30AM |
Coffee Break |
|
11:30AM – 12:45PM |
Session 2 |
Now for Something Completely Different: How will Pharma Access External Early-Stage Innovation? |
Coverage and Reimbursement Risks: The Influence of Deficit Reduction and Other Pressures |
Patient Access to Developmental Drugs |
Blueprint for Success: Which Biotech Business Model Works Best for You? |
|
12:45PM – 1:15PM |
Lunch |
|
|
1:15PM – 2:30PM |
|
|
2:30PM – 3:45PM |
Session 3 |
Leading Edge Tools, Technologies and Approaches for Drug Discovery |
Regulating Diagnostics: Anticipating the Path Forward |
Social Media and Life Sciences: Hearing a Patient’s Voice |
Biotech Then and Now: What Does Biotech Look Like 10 Years from Now? |
Partnering |
|
|
3:45PM – 5:00PM |
Closing Reception |
